Inez Neymar success is down to Messi, says father KARACHI:After announcing the results of intermediate arts students and special group, Board of Intermediate Education Karachi (BIEK) has finished the results declarations for the year 2016.A total of 60% candidat [url=https://www.nbbalance.it%5Dnb%5B/url] es failed to pass their annual examinations for intermediate in arts. "The results have been consistently the same since the [url=https://www.adidas-samba-adidas.fr%5Dadidas samba og[/url] last three years and it is sad to see that our students are failing to perform better in arts," said examination controller Imran Khan Chishti while announcing the result in the award ceremony at the BIEK office on Monday."The education department should take strong steps and actions should be taken against why there is no concept of regular classes and also review the admission policy," he added.Complaining about the promised scholarships, BIEK chairperson Akhter Ghauri said that announced scholarships to last year's position holders have yet to be approved. He said he wil [url=https://www.adidas-samba-adidas.it%5Dadidas samba og[/url] l also write to the chief minister to get the scholarships approved and announce mo Ce [url=https://www.adidas-yeezy.de%5Dadidas yeezys[/url] llCyte Genetics Corporation is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased organs, such as the heart.Along with its planned human trials for its therapeutics, CellCyte Genetics intends to develop a new [url=https://www.nbbalance.de%5Dnew balance 480[/url] stem cell cultivation device or "bioreactor" unit for which CellCyte Genetics owns the [url=https://www.nbbalance.de%5Dnew balance 327[/url] worldwide patent and rights. The Company plans to market the device for applications that will require cells to be grown under regulated oxygen concentrations, e.g. the replication of stem cells and the culture of pancreatic islet cells prior to transplantation into diabetic patients.Dr. Ron Berninger, Chief Scientific Officer of CellCyte Genetics explains, "CellCyte's patented biological cell maintenance system has the unique ability to incubate cultured cells with a very efficient and regulatable oxygen supply, making it an ideal choice for culturing cells that are otherwise diffic